Safety of bevacizumab (B) and erlotinib (E) therapy in patients (pts) with treated brain metastases (mets) in the phase III, placebo (P)-controlled, randomized BeTa trial for pts with advanced non-small cell lung cancer (NSCLC) after failure of standard first-line chemotherapy
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: G. A. Otterson, P. G. O’Connor, M. Lin, R. S. Herbst, for the BETA Lung Investigators
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602204204